| Product Code: ETC9517806 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Suriname Oncology Market Overview |
3.1 Suriname Country Macro Economic Indicators |
3.2 Suriname Oncology Market Revenues & Volume, 2021 & 2031F |
3.3 Suriname Oncology Market - Industry Life Cycle |
3.4 Suriname Oncology Market - Porter's Five Forces |
3.5 Suriname Oncology Market Revenues & Volume Share, By Cancer Type, 2021 & 2031F |
3.6 Suriname Oncology Market Revenues & Volume Share, By End-use, 2021 & 2031F |
4 Suriname Oncology Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in Suriname |
4.2.2 Growing investment in healthcare infrastructure |
4.2.3 Rising awareness about cancer screening and early detection |
4.3 Market Restraints |
4.3.1 Limited access to advanced oncology treatments in Suriname |
4.3.2 High treatment costs and affordability issues for patients |
4.3.3 Lack of specialized oncology healthcare professionals |
5 Suriname Oncology Market Trends |
6 Suriname Oncology Market, By Types |
6.1 Suriname Oncology Market, By Cancer Type |
6.1.1 Overview and Analysis |
6.1.2 Suriname Oncology Market Revenues & Volume, By Cancer Type, 2021- 2031F |
6.1.3 Suriname Oncology Market Revenues & Volume, By Lung cancer, 2021- 2031F |
6.1.4 Suriname Oncology Market Revenues & Volume, By Prostate cancer, 2021- 2031F |
6.1.5 Suriname Oncology Market Revenues & Volume, By Colon & rectal cancer, 2021- 2031F |
6.1.6 Suriname Oncology Market Revenues & Volume, By Gastric cancer, 2021- 2031F |
6.1.7 Suriname Oncology Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Suriname Oncology Market, By End-use |
6.2.1 Overview and Analysis |
6.2.2 Suriname Oncology Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.2.3 Suriname Oncology Market Revenues & Volume, By Diagnostic laboratories, 2021- 2031F |
6.2.4 Suriname Oncology Market Revenues & Volume, By Diagnostic imaging centers, 2021- 2031F |
6.2.5 Suriname Oncology Market Revenues & Volume, By Academia, 2021- 2031F |
6.2.6 Suriname Oncology Market Revenues & Volume, By Specialty clinics, 2021- 2031F |
6.2.7 Suriname Oncology Market Revenues & Volume, By Others, 2021- 2031F |
7 Suriname Oncology Market Import-Export Trade Statistics |
7.1 Suriname Oncology Market Export to Major Countries |
7.2 Suriname Oncology Market Imports from Major Countries |
8 Suriname Oncology Market Key Performance Indicators |
8.1 Average waiting time for cancer treatment |
8.2 Number of oncology clinical trials conducted in Suriname |
8.3 Percentage of cancer patients receiving timely diagnosis and treatment |
8.4 Patient satisfaction with oncology care services |
8.5 Adoption rate of new oncology technologies and treatments |
9 Suriname Oncology Market - Opportunity Assessment |
9.1 Suriname Oncology Market Opportunity Assessment, By Cancer Type, 2021 & 2031F |
9.2 Suriname Oncology Market Opportunity Assessment, By End-use, 2021 & 2031F |
10 Suriname Oncology Market - Competitive Landscape |
10.1 Suriname Oncology Market Revenue Share, By Companies, 2024 |
10.2 Suriname Oncology Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here